{"id":"docosanol-10","safety":{"commonSideEffects":[{"rate":null,"effect":"Application site reactions (irritation, redness)"},{"rate":null,"effect":"Headache"}]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"Docosanol works by blocking the fusion process between the herpes simplex virus envelope and the host cell membrane, preventing viral entry into cells. This mechanism reduces viral replication and spread. It is thought to act as a broad-spectrum antiviral by altering membrane fluidity and preventing the virus from establishing infection.","oneSentence":"Docosanol is a long-chain saturated alcohol that inhibits viral entry and replication by interfering with the fusion of viral and cellular membranes.","_ai_confidence":"medium"},"_scrapedAt":"2026-03-28T00:35:32.284Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Herpes simplex labialis (cold sores) — topical treatment"}]},"trialDetails":[{"nctId":"NCT04872946","phase":"NA","title":"Topical and Oral Regimen for Skin Health","status":"COMPLETED","sponsor":"Integrative Skin Science and Research","startDate":"2019-11-26","conditions":"Skin Abnormalities","enrollment":74},{"nctId":"NCT03977792","phase":"PHASE2","title":"An Open Label Study to Evaluate the Safety and Efficacy of BOR15001L7 for the Treatment of Cold Sores in Patients With Recurrent Herpes Labialis","status":"UNKNOWN","sponsor":"Laboratoire Boreaderme Inc.","startDate":"2020-09","conditions":"Recurrent Herpes Labialis","enrollment":164},{"nctId":"NCT00467662","phase":"PHASE4","title":"Comparison of Topical Antiviral Agents for Labial Cold Sores (Herpes Labialis)","status":"UNKNOWN","sponsor":"Hadassah Medical Organization","startDate":"","conditions":"Reccurent Herpes Labialis","enrollment":75}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":4,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"marketed","status":"active","brandName":"Docosanol 10%","genericName":"Docosanol 10%","companyName":"Hadassah Medical Organization","companyId":"hadassah-medical-organization","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Docosanol is a long-chain saturated alcohol that inhibits viral entry and replication by interfering with the fusion of viral and cellular membranes. Used for Herpes simplex labialis (cold sores) — topical treatment.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}